22nd Century Group Cash Conversion Cycle 2011-2026 | XXII

Annual Cash Conversion Cycle 22nd Century Group

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
108	19	98.1	63.7	83.7	40.6	16	18.7	46.4	51.5	59.3	896	1.07 K	-179	-329

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.07 K	-329	138

Quarterly Cash Conversion Cycle 22nd Century Group

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
73	73.2	31.6	-	3.24	-15.8	-0.32	-	284	236	189	-	51.7	44.5	24.5	-	35.1	33.6	39	27	39	44	27.6	10.9	16	17.8	17.9	11.1	19.7	17.8	26.2	14.7	41.8	49.4	20.4	1.12	1.21	1.32	1.39	1.59	45.8	2.03	3.79	-	352	-	-	-	6 K	-	-	-	-	-	-	-	20.4	44.2	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
6 K	-15.8	186

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Verastem VSTM	38.5	$ 5.04	-4.73 %	$ 349 M	USA
Voyager Therapeutics VYGR	14.8	$ 3.96	-4.12 %	$ 232 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	-54.4	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Avid Bioservices CDMO	85.5	-	-	$ 789 M	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	72.3	$ 12.41	-11.1 %	$ 1.88 B	USA
Wave Life Sciences Ltd. WVE	11.5	$ 6.37	2.66 %	$ 1.07 B	Singapore
Xenetic Biosciences XBIO	-1.84 K	$ 2.72	-2.86 %	$ 4.63 M	USA
XBiotech XBIT	-1.26 K	$ 2.27	-1.73 %	$ 69.2 M	USA
Xenon Pharmaceuticals XENE	72.6	$ 54.48	-1.89 %	$ 4.24 B	Canada
Xeris Pharmaceuticals XERS	535	$ 5.4	-3.05 %	$ 866 M	USA
X4 Pharmaceuticals XFOR	-408	$ 4.04	-6.26 %	$ 171 M	USA
Xencor XNCR	131	$ 11.42	-7.23 %	$ 848 M	USA
XOMA Corporation XOMA	23.6	$ 30.17	-1.18 %	$ 364 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Zai Lab Limited ZLAB	-46.6	$ 18.0	2.8 %	$ 19.7 B	China
Enlivex Therapeutics Ltd. ENLV	-193	$ 1.05	-3.67 %	$ 21.5 M	Israel